Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arginine gingipains are a group of arginine-specific cysteine proteases produced by the bacterium *Porphyromonas gingivalis*, a major pathogen implicated in chronic periodontitis. These enzymes, primarily RgpA and RgpB, are key virulence factors that contribute to bacterial colonization, immune evasion, and tissue destruction in periodontal disease. They are considered therapeutic targets for the treatment of periodontitis.
Inhibition of arginine-specific cysteine protease activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arginine Gingipain (Rgp).